|
US6143548A
(en)
*
|
1995-08-30 |
2000-11-07 |
Genzyme Corporation |
Chromatographic purification of adeno-associated virus (AAV)
|
|
US20020088014A1
(en)
*
|
1996-05-31 |
2002-07-04 |
Xiangming Fang |
Minimal adenovirus mediated recombinant vaccine
|
|
BR9710030A
(pt)
|
1996-07-01 |
1999-08-10 |
Rhone Poulenc Rorer Sa |
Processo de produção de adenovírus recombinantes processo de purificação de adenovírus recombinantes a partir de um meio biológico preparação viral purificada composição farmacêutica e utilização de iodixanol-5,5'-[(2-Hidroxipropil-1,3-Propanottl)-Bis[N,N'-Bis(2,3-Didroxipropil-2,4,6-Triodo-1,3-Benzenocarboxamida]
|
|
US7732129B1
(en)
|
1998-12-01 |
2010-06-08 |
Crucell Holland B.V. |
Method for the production and purification of adenoviral vectors
|
|
JP4492826B2
(ja)
*
|
1996-11-20 |
2010-06-30 |
イントロジェン セラピューティクス，インコーポレイテッド |
アデノウイルスベクターの産生および精製のための改良された方法
|
|
US6261823B1
(en)
|
1996-12-13 |
2001-07-17 |
Schering Corporation |
Methods for purifying viruses
|
|
US6544769B1
(en)
|
1996-12-13 |
2003-04-08 |
Schering Corporation |
Compostions comprising viruses and methods for concentrating virus preparations
|
|
US6995006B2
(en)
*
|
1997-09-05 |
2006-02-07 |
Targeted Genetics Corporation |
Methods for generating high titer helper-free preparations of released recombinant AAV vectors
|
|
IL135776A0
(en)
*
|
1997-10-24 |
2001-05-20 |
Life Technologies Inc |
Recombinational cloning using nucleic acids having recombination sites
|
|
US7705602B2
(en)
*
|
1997-11-03 |
2010-04-27 |
Midtronics, Inc. |
Automotive vehicle electrical system diagnostic device
|
|
US20040204381A1
(en)
*
|
1997-11-12 |
2004-10-14 |
Moskal Joseph R |
Detection and treatment of glyco-enzyme-related disease
|
|
US6899870B1
(en)
*
|
1998-03-11 |
2005-05-31 |
Board Of Regents, The University Of Texas System |
Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery
|
|
US6383795B1
(en)
*
|
1998-04-22 |
2002-05-07 |
Genvec, Inc. |
Efficient purification of adenovirus
|
|
WO2000022152A1
(en)
*
|
1998-10-13 |
2000-04-20 |
Avigen, Inc. |
Compositions and methods for producing recombinant adeno-associated virus
|
|
US7691370B2
(en)
*
|
1998-10-15 |
2010-04-06 |
Canji, Inc. |
Selectivity replicating viral vector
|
|
EP1977764A1
(en)
*
|
1998-11-16 |
2008-10-08 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US6689600B1
(en)
|
1998-11-16 |
2004-02-10 |
Introgen Therapeutics, Inc. |
Formulation of adenovirus for gene therapy
|
|
US7148035B1
(en)
*
|
1998-11-18 |
2006-12-12 |
Oxford Biomedica (Uk) Limited |
Polypeptide
|
|
US6210922B1
(en)
*
|
1998-11-30 |
2001-04-03 |
National Research Council Of Canada |
Serum free production of recombinant proteins and adenoviral vectors
|
|
PL349074A1
(en)
|
1998-12-31 |
2002-07-01 |
Aventis Pharma Sa |
Method for separating viral particles
|
|
FR2788064B1
(fr)
*
|
1998-12-31 |
2003-01-31 |
Aventis Pharma Sa |
Methode de separation de particules virales
|
|
DE60029195T2
(de)
|
1999-02-22 |
2007-06-28 |
Transgene S.A. |
Verfahren zur Gewinnung von purifizierter Virenzusammensetzung
|
|
US6795585B1
(en)
|
1999-07-16 |
2004-09-21 |
Eastman Kodak Company |
Representing digital images in a plurality of image processing states
|
|
WO2001048155A2
(en)
*
|
1999-12-29 |
2001-07-05 |
Genzyme Corporation |
Method using filtration aids for the separation of virus vectors from nucleic acids and other cellular contaminants
|
|
US6168941B1
(en)
*
|
2000-04-07 |
2001-01-02 |
Genvec, Inc. |
Method of producing adenoviral vector stocks
|
|
AU2001257420A1
(en)
*
|
2000-04-28 |
2001-11-12 |
Zengen, Inc. |
A gene therapy system and method using alpha-MSH and its derivatives
|
|
US6783939B2
(en)
*
|
2000-07-07 |
2004-08-31 |
Alphavax, Inc. |
Alphavirus vectors and virosomes with modified HIV genes for use in vaccines
|
|
TWI289158B
(en)
*
|
2000-08-10 |
2007-11-01 |
Oncolytics Biotech Inc |
Method of producing infectious reovirus
|
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
|
US20020064860A1
(en)
*
|
2000-11-29 |
2002-05-30 |
Schering Corporation |
Method for purifying adenoviruses
|
|
IL157304A0
(en)
|
2001-03-16 |
2004-02-19 |
Oncolytics Biotech Inc |
Method of extracting virus from cell culture
|
|
US20040146590A1
(en)
|
2001-03-22 |
2004-07-29 |
Iadarola Michael J |
Molecular neurochirurgie for pain control administering locally capsaicin or resinferatoxin
|
|
NZ528462A
(en)
*
|
2001-03-27 |
2005-11-25 |
Vertex Pharma |
Compositions and methods useful for HCV infection
|
|
WO2003014367A1
(en)
|
2001-08-08 |
2003-02-20 |
The Trustees Of The University Of Pennsylvania |
Method for purification of viral vectors having proteins which bind sialic acid
|
|
AU2002332736A1
(en)
*
|
2001-08-30 |
2003-03-18 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of |
New adenovirus type 7 vectors
|
|
US7045335B2
(en)
*
|
2001-09-06 |
2006-05-16 |
Alphavax, Inc. |
Alphavirus replicon vector systems
|
|
AU2002348151A1
(en)
*
|
2001-11-05 |
2003-05-19 |
Genvec, Inc. |
Viral vector production methods and compositions
|
|
NZ533586A
(en)
*
|
2001-12-20 |
2005-02-25 |
Bavarian Nordic As |
Method for the recovery and purification of poxviruses from infected cells using high pressure homogenisation
|
|
KR100451308B1
(ko)
*
|
2001-12-28 |
2004-10-06 |
선바이오(주) |
단백질 의약품 정제 방법에서의 바이러스 제거 방법
|
|
WO2003068163A2
(en)
*
|
2002-02-14 |
2003-08-21 |
Novavax, Inc. |
Optimization of gene sequences of chimeric virus-like particles for expression in insect cells
|
|
US7316898B2
(en)
*
|
2002-02-20 |
2008-01-08 |
Merck & Co., Inc. |
Method of determining adenovirus particle concentration
|
|
US20030175688A1
(en)
*
|
2002-03-15 |
2003-09-18 |
Rukmini Pennathur-Das |
Method for the purification and production of oncolytic adenoviruses
|
|
US20030180936A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Memarzadeh Bahram Eric |
Method for the purification, production and formulation of oncolytic adenoviruses
|
|
US20030186832A1
(en)
*
|
2002-03-15 |
2003-10-02 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Isotropic liquid detergents with improved anti-redeposition
|
|
CA2478932A1
(en)
*
|
2002-03-29 |
2003-10-16 |
Merck & Co., Inc. |
Large scale methods of producing adenovirus and adenovirus seed stocks
|
|
JP2005523722A
(ja)
*
|
2002-04-30 |
2005-08-11 |
オンコリティクス バイオテック， インコーポレイティッド |
改善されたウイルス精製方法
|
|
ES2285120T3
(es)
|
2002-05-14 |
2007-11-16 |
MERCK & CO., INC. |
Procedimientos de purificacion de adenovirus.
|
|
US20030224354A1
(en)
*
|
2002-05-30 |
2003-12-04 |
Introgen Therapeutics Inc. |
Quantifying viral particles with intrinsic fluorescence
|
|
EP1371723A1
(en)
*
|
2002-06-12 |
2003-12-17 |
Procorde GmbH |
Process for preparing an adenovirus-containing preparation
|
|
US20040219516A1
(en)
*
|
2002-07-18 |
2004-11-04 |
Invitrogen Corporation |
Viral vectors containing recombination sites
|
|
CA2496918A1
(en)
*
|
2002-08-28 |
2004-03-11 |
Introgen Therapeutics Inc. |
Chromatographic methods for adenovirus purification
|
|
US20050282814A1
(en)
*
|
2002-10-03 |
2005-12-22 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
US7208493B2
(en)
*
|
2002-10-03 |
2007-04-24 |
Targegen, Inc. |
Vasculostatic agents and methods of use thereof
|
|
US7319021B2
(en)
*
|
2002-11-01 |
2008-01-15 |
Promega Corporation |
Cell lysis composition, methods of use, apparatus and kit
|
|
DK1585812T3
(en)
|
2002-12-13 |
2017-04-10 |
Alphavax Inc |
MULTI-ANTI-ANTI-ANTI-VIRUS REPLICATE PARTICLES AND PROCEDURES
|
|
WO2004055167A2
(en)
*
|
2002-12-13 |
2004-07-01 |
Alphavax, Inc. |
Alphavirus particles and methods for preparation
|
|
JP2006516548A
(ja)
|
2002-12-30 |
2006-07-06 |
アンジオテック インターナショナル アクツィエン ゲゼルシャフト |
迅速ゲル化ポリマー組成物からの薬物送達法
|
|
EP2561887B8
(en)
|
2003-01-14 |
2016-12-21 |
Dana-Farber Cancer Institute, Inc. |
Cancer therapy sensitizer
|
|
KR101518309B1
(ko)
*
|
2003-03-20 |
2015-05-08 |
알파벡스, 인크. |
개선된 알파바이러스 레플리콘 및 헬퍼 구축물
|
|
ES2290705T3
(es)
*
|
2003-05-01 |
2008-02-16 |
Dsm Ip Assets B.V. |
Proceso para la produccion de sustancias biologicas por cultivo por perfusion de celulas animales suspendidas.
|
|
US20040229335A1
(en)
*
|
2003-05-15 |
2004-11-18 |
Introgen Therapeutics, Inc. |
Methods and compositions for the production of adenoviral vectors
|
|
WO2004112707A2
(en)
*
|
2003-06-18 |
2004-12-29 |
Onyx Pharmaceuticals, Inc. |
Method for purifying virus
|
|
US7419674B2
(en)
*
|
2003-07-11 |
2008-09-02 |
Alpha Vax, Inc. |
Alpha virus-based cytomegalovirus vaccines
|
|
EP1944318B1
(en)
|
2003-07-21 |
2011-03-02 |
Transgene S.A. |
Multifunctional cytokines
|
|
ATE469984T1
(de)
|
2003-12-01 |
2010-06-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
|
EP1697505A1
(en)
*
|
2003-12-23 |
2006-09-06 |
Schering Corporation |
Methods for producing a549 cell lines stable in serum-free medium suspension culture
|
|
WO2005080556A2
(en)
*
|
2004-02-23 |
2005-09-01 |
Crucell Holland B.V. |
Virus purification methods
|
|
CN100333797C
(zh)
*
|
2005-01-26 |
2007-08-29 |
彭朝晖 |
重组腺病毒p53制品在肿瘤治疗中的新用途
|
|
NZ551027A
(en)
*
|
2004-04-08 |
2011-01-28 |
Targegen Inc |
Benzotriazine inhibitors of kinases
|
|
EP1751289B1
(en)
*
|
2004-05-18 |
2009-01-14 |
Alphavax, Inc. |
Tc-83-derived alphavirus vectors, particles and methods
|
|
DK3290513T3
(da)
*
|
2004-06-01 |
2022-12-12 |
Genzyme Corp |
Sammensætninger og fremgangsmåder til forhindring af aav-vektoraggregering
|
|
US20050287616A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Gross Adam F |
Method of assaying denaturation of proteins
|
|
JP5275628B2
(ja)
|
2004-08-25 |
2013-08-28 |
ターゲジェン インコーポレーティッド |
複素環式化合物および使用方法
|
|
DE202004014949U1
(de)
*
|
2004-09-25 |
2004-11-18 |
Techno-Grafica Gmbh |
Vorrichtung zum Wärmebehandeln einer Beschichtung von Flachoffset-Druckplatten
|
|
DE102004049290A1
(de)
*
|
2004-10-09 |
2006-04-20 |
Bayer Healthcare Ag |
Verfahren zur Herstellung von Virusmaterial
|
|
US7901921B2
(en)
*
|
2004-10-22 |
2011-03-08 |
Oncolytics Biotech Inc. |
Viral purification methods
|
|
JP2008518632A
(ja)
*
|
2004-11-03 |
2008-06-05 |
イントロゲン セラピューティックス， インコーポレイテッド |
アデノウイルスベクターの製造および精製のための新規方法
|
|
CN100497640C
(zh)
*
|
2004-11-26 |
2009-06-10 |
中国人民解放军军事医学科学院生物工程研究所 |
一种高效生产重组腺病毒载体的方法
|
|
US20060166364A1
(en)
*
|
2004-12-22 |
2006-07-27 |
Introgen, Inc. |
Use of flexible bag containers for viral production
|
|
ATE547511T1
(de)
*
|
2004-12-23 |
2012-03-15 |
Medimmune Llc |
Nichttumorbildende mdck-zellinie zur vermehrung von viren
|
|
US20060205080A1
(en)
*
|
2005-03-01 |
2006-09-14 |
David Frey |
Formulations for therapeutic viruses having enhanced storage stability
|
|
WO2006099875A1
(en)
|
2005-03-23 |
2006-09-28 |
Genmab A/S |
Antibodies against cd38 for treatment of multiple myeloma
|
|
CA2602944C
(en)
*
|
2005-04-11 |
2015-08-11 |
Crucell Holland B.V. |
Virus purification using ultrafiltration
|
|
US20060263415A1
(en)
*
|
2005-05-05 |
2006-11-23 |
Sensient Flavors Inc. |
Production of beta-glucans and mannans
|
|
WO2006133411A1
(en)
*
|
2005-06-08 |
2006-12-14 |
Targegen, Inc. |
Methods and compositions for the treatment of ocular disorders
|
|
US20090216452A1
(en)
*
|
2005-07-05 |
2009-08-27 |
Develop Tech Resources |
Energy recovery within a fluid distribution network using geographic information
|
|
US8604042B2
(en)
*
|
2005-11-01 |
2013-12-10 |
Targegen, Inc. |
Bi-aryl meta-pyrimidine inhibitors of kinases
|
|
BR122021011787B1
(pt)
*
|
2005-11-01 |
2022-01-25 |
Impact Biomedicines, Inc |
Inibidores de biaril meta pirimidina de cinases, composição farmacêutica e processo para preparar uma composição farmacêutica
|
|
US8133900B2
(en)
*
|
2005-11-01 |
2012-03-13 |
Targegen, Inc. |
Use of bi-aryl meta-pyrimidine inhibitors of kinases
|
|
DE602007009954D1
(de)
*
|
2006-03-22 |
2010-12-02 |
Viral Logic Systems Technology |
Verfahren zur identifizierung von polypeptid-targets
|
|
US7691858B2
(en)
*
|
2006-04-25 |
2010-04-06 |
Targegen, Inc. |
Kinase inhibitors and methods of use thereof
|
|
KR101464783B1
(ko)
|
2006-09-15 |
2014-11-26 |
메디뮨 엘엘씨 |
높은 역가로 바이러스 증식을 지원하는 ｍｄｃｋ 세포주 및 이를 이용한 생물반응기 공정
|
|
AR065076A1
(es)
|
2007-01-30 |
2009-05-13 |
Transgene Sa |
Vacuna contra el papilomavirus
|
|
US20080299624A1
(en)
*
|
2007-06-01 |
2008-12-04 |
Edward Heslop |
Continuous fermentation apparatus and method
|
|
EP2183368B1
(en)
*
|
2007-06-21 |
2016-08-10 |
Alphavax, Inc. |
Promoterless cassettes for expression of alphavirus structural proteins
|
|
HUE035406T2
(en)
*
|
2007-10-08 |
2018-05-02 |
Intrexon Corp |
Engineered dendritic cells and uses for the treatment of cancer
|
|
PT2222697E
(pt)
|
2007-11-01 |
2013-02-15 |
Perseid Therapeutics Llc |
Polipeptídeos imunossupressores e ácidos nucleicos
|
|
US20090253184A1
(en)
*
|
2008-01-23 |
2009-10-08 |
Introgen Therapeutics, Inc. |
Compositions and methods related to an adenoviral trans-complementing cell line
|
|
US10316352B2
(en)
*
|
2008-05-13 |
2019-06-11 |
Gen-Probe Incorporated |
Methods of capturing a target nucleic acid for amplification and detection using an inactivatable target capture oligomer
|
|
EP3192874B1
(en)
*
|
2008-06-18 |
2019-10-16 |
Oxford BioMedica (UK) Limited |
Virus purification
|
|
EP2344634A4
(en)
*
|
2008-09-24 |
2012-08-29 |
Medimmune Llc |
METHODS OF CELL CULTURE, AND PROPAGATION AND PURIFICATION OF VIRUSES
|
|
EP2334328A4
(en)
*
|
2008-09-24 |
2012-08-29 |
Medimmune Llc |
METHOD FOR CLEANING VIRUSES
|
|
US20110262483A1
(en)
*
|
2008-11-03 |
2011-10-27 |
Ligocyte Pharmaceuticals, Inc. |
Methods for isolating enveloped virus-based vlps free of infectious agents
|
|
EA019928B1
(ru)
|
2008-11-03 |
2014-07-30 |
Круселл Холланд Б.В. |
Способ получения аденовирусных векторов
|
|
US9523344B2
(en)
*
|
2009-05-26 |
2016-12-20 |
Leviathan Energy Hydroelectric Ltd. |
Hydroelectric in-pipe turbine uses
|
|
CN103335930A
(zh)
*
|
2009-07-07 |
2013-10-02 |
索尼公司 |
微流体装置
|
|
US9393299B2
(en)
|
2009-08-07 |
2016-07-19 |
Transgene S.A. |
Composition for treating HBV infection
|
|
WO2011045378A1
(en)
|
2009-10-15 |
2011-04-21 |
Crucell Holland B.V. |
Method for the purification of adenovirus particles
|
|
MX2012004221A
(es)
|
2009-10-15 |
2012-06-08 |
Crucell Holland Bv |
Proceso para purificacion de adenovirus de cultivos de alta densidad celular.
|
|
KR101754437B1
(ko)
|
2010-01-05 |
2017-07-05 |
바스큘라 바이오제닉스 리미티드 |
특이적 항-혈관형성 아데노바이러스제의 사용방법
|
|
US20130209450A1
(en)
|
2010-01-05 |
2013-08-15 |
Yael Cohen |
Compositions and Methods for Treating Glioblastoma GBM
|
|
JP6009357B2
(ja)
*
|
2010-01-12 |
2016-10-19 |
バスキュラー バイオジェニックス リミテッド |
アデノウイルスベクターの生産方法およびそれによって生成されるウイルス調製物
|
|
BR112012019023B1
(pt)
|
2010-02-15 |
2021-12-21 |
Janssen Vaccines & Prevention B.V. |
Método para produzir adenovírus recombinante sorotipo 26 (rad26), e, uso de um biorreator
|
|
JP2013523175A
(ja)
|
2010-04-14 |
2013-06-17 |
イーエムディー・ミリポア・コーポレーション |
高力価、高純度のウイルスストックの作製方法及びその使用方法
|
|
SG188947A1
(en)
|
2010-08-12 |
2013-06-28 |
Yisheng Biopharma Holdings Ltd |
Method for reducing dna impurities in viral compositions
|
|
EP2618838A1
(en)
|
2010-09-20 |
2013-07-31 |
Crucell Holland B.V. |
Therapeutic vaccination against active tuberculosis
|
|
CA2809463C
(en)
|
2010-09-27 |
2021-05-25 |
Crucell Holland B.V. |
Heterologous prime boost vaccination regimen against malaria
|
|
US8892184B2
(en)
|
2010-10-18 |
2014-11-18 |
Siemens Medical Solutions Usa, Inc. |
Systems and methods for reducing interference in a dual modality imaging system
|
|
CA2816957A1
(en)
|
2010-11-07 |
2012-05-10 |
Targegen, Inc. |
Compositions and methods for treating myelofibrosis
|
|
EP2461162A1
(en)
|
2010-12-03 |
2012-06-06 |
Texcell, . |
Method for determining the titre of viruses by using infectious standards
|
|
BR112013014457A8
(pt)
|
2010-12-09 |
2017-12-19 |
Pasteur Institut |
usos da enzima 6-metilguanina-dna-metiltrasferase (mgmt, ec 2.1.1.63) para aumentar a produção de proteína heteróloga, bem como vetor de expressão, células recombinantes e polipeptídeo de fusão compreendendo sinal de secreção peptídica e proteína snap
|
|
TWI575070B
(zh)
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Ｈｂｖ聚合酶突變體
|
|
WO2013045668A2
(en)
|
2011-09-29 |
2013-04-04 |
Transgene Sa |
Immunotherapy composition and regimen for treating hepatitis c virus infection
|
|
TW201318637A
(zh)
|
2011-09-29 |
2013-05-16 |
Transgene Sa |
免疫療法組成物及用於治療ｃ型肝炎病毒感染之療程（一）
|
|
EP2780034A1
(en)
|
2011-11-14 |
2014-09-24 |
Crucell Holland B.V. |
Heterologous prime-boost immunization using measles virus-based vaccines
|
|
US8932607B2
(en)
|
2012-03-12 |
2015-01-13 |
Crucell Holland B.V. |
Batches of recombinant adenovirus with altered terminal ends
|
|
HUE027839T2
(en)
|
2012-03-12 |
2016-11-28 |
Crucell Holland Bv |
Recombinant adenoviruses with altered terminals
|
|
NZ630753A
(en)
|
2012-03-22 |
2016-12-23 |
Janssen Vaccines & Prevention Bv |
Vaccine against rsv
|
|
US9125870B2
(en)
|
2012-03-22 |
2015-09-08 |
Crucell Holland B.V. |
Vaccine against RSV
|
|
CA2878898C
(en)
*
|
2012-07-26 |
2023-01-17 |
Vectalys |
Method for detecting or measuring the impact of a viral vector composition on eukaryotic cells and biomarkers used thereof
|
|
WO2014066443A1
(en)
|
2012-10-23 |
2014-05-01 |
Emory University |
Gm-csf and il-4 conjugates, compositions, and methods related thereto
|
|
DK2988780T3
(en)
|
2013-04-25 |
2019-04-08 |
Janssen Vaccines & Prevention Bv |
STABILIZED SOLVEN RSV-F PREFUSION POLYPTIDES
|
|
US9520347B2
(en)
|
2013-05-03 |
2016-12-13 |
Honeywell International Inc. |
Lead frame construct for lead-free solder connections
|
|
CA2914792C
(en)
|
2013-06-17 |
2024-02-27 |
Crucell Holland B.V. |
Stabilized soluble pre-fusion rsv f polypeptides
|
|
US9956166B2
(en)
|
2013-09-18 |
2018-05-01 |
Sorrento Therapeutics, Inc. |
Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
|
|
WO2015062699A1
(en)
*
|
2013-10-30 |
2015-05-07 |
Merck Patent Gmbh |
Method for isolating microorganisms from a complex sample
|
|
EP3107683B1
(en)
|
2014-02-20 |
2021-12-08 |
Honeywell International Inc. |
Method of forming a solder wire
|
|
CN106232800B
(zh)
|
2014-03-25 |
2020-07-03 |
泰尔茂比司特公司 |
介质的被动替代
|
|
KR20250005450A
(ko)
|
2014-04-25 |
2025-01-09 |
샤이어 휴먼 지네틱 테라피즈 인크. |
메신저 rna 의 정제 방법
|
|
EP3151866B1
(en)
|
2014-06-09 |
2023-03-08 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
CN105316296A
(zh)
*
|
2014-06-13 |
2016-02-10 |
亚宝药业太原制药有限公司 |
一种纯化腺病毒颗粒的方法
|
|
JP2017527310A
(ja)
|
2014-09-09 |
2017-09-21 |
ユーナム・セラピューティクスＵｎｕｍ Ｔｈｅｒａｐｅｕｔｉｃｓ |
キメラ受容体および免疫療法におけるその使用
|
|
GB201417042D0
(en)
*
|
2014-09-29 |
2014-11-12 |
Fkd Therapies Oy |
Method
|
|
CN107106689A
(zh)
|
2014-11-05 |
2017-08-29 |
沃雅戈治疗公司 |
用于治疗帕金森病的aadc多核苷酸
|
|
IL292999A
(en)
|
2014-11-14 |
2022-07-01 |
Voyager Therapeutics Inc |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
MX2017006217A
(es)
|
2014-11-14 |
2018-05-02 |
Voyager Therapeutics Inc |
Polinucleotidos moduladores.
|
|
US11697825B2
(en)
|
2014-12-12 |
2023-07-11 |
Voyager Therapeutics, Inc. |
Compositions and methods for the production of scAAV
|
|
SG11201704919SA
(en)
|
2015-01-13 |
2017-07-28 |
Alfa Wassermann Inc |
Methods of purifying adeno-associated virus (aav) and/or recombinant adeno-associated virus (raav)
|
|
EP3054007A1
(en)
|
2015-02-09 |
2016-08-10 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Recombinant adeno-associated virus particle purification comprising an immuno-affinity purification step
|
|
WO2016128542A1
(en)
|
2015-02-13 |
2016-08-18 |
Transgene Sa |
Immunotherapeutic vaccine and antibody combination therapy
|
|
WO2016131945A1
(en)
|
2015-02-20 |
2016-08-25 |
Transgene Sa |
Combination product with autophagy modulator
|
|
CA2981841A1
(en)
|
2015-04-14 |
2016-10-20 |
Janssen Vaccines & Prevention B.V. |
Recombinant adenovirus expressing two transgenes with a bidirectional promoter
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
EP3821906A1
(en)
|
2015-07-07 |
2021-05-19 |
Janssen Vaccines & Prevention B.V. |
Vaccine against rsv comprising modified f polypeptide
|
|
US10457708B2
(en)
|
2015-07-07 |
2019-10-29 |
Janssen Vaccines & Prevention B.V. |
Stabilized soluble pre-fusion RSV F polypeptides
|
|
US9663766B2
(en)
|
2015-07-24 |
2017-05-30 |
Bio-Rad Laboratories, Inc. |
Methods for purifying adenovirus vectors
|
|
CN108290939B
(zh)
|
2015-10-16 |
2023-01-13 |
纽约市哥伦比亚大学理事会 |
用于抑制谱系特异性抗原的组合物和方法
|
|
US20180230489A1
(en)
|
2015-10-28 |
2018-08-16 |
Voyager Therapeutics, Inc. |
Regulatable expression using adeno-associated virus (aav)
|
|
MA52910A
(fr)
|
2016-04-05 |
2021-04-21 |
Janssen Vaccines & Prevention Bv |
Protéine f de pré-fusion du vrs soluble et stabilisée pour son utilisation dans la prophylaxie d'un infection vrs
|
|
WO2017174564A1
(en)
|
2016-04-05 |
2017-10-12 |
Janssen Vaccines & Prevention B.V. |
Vaccine against rsv
|
|
LT3722435T
(lt)
|
2016-04-14 |
2025-10-10 |
|
Fiksuoto lovio bioreaktorius su nuolatinio srauto siurbliu / vamzdžių sistema
|
|
CA3021070A1
(en)
*
|
2016-04-14 |
2017-10-19 |
Trizell Ltd. |
Fixed-bed bioreactor with constant-flow pump/tubing system
|
|
US11326182B2
(en)
|
2016-04-29 |
2022-05-10 |
Voyager Therapeutics, Inc. |
Compositions for the treatment of disease
|
|
EP3448987A4
(en)
|
2016-04-29 |
2020-05-27 |
Voyager Therapeutics, Inc. |
COMPOSITIONS FOR TREATING A DISEASE
|
|
US20190134190A1
(en)
|
2016-05-04 |
2019-05-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
|
EP3458589A4
(en)
|
2016-05-18 |
2020-01-01 |
Voyager Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATING MORBUS HUNTINGTON
|
|
MX2018014154A
(es)
|
2016-05-18 |
2019-05-06 |
Voyager Therapeutics Inc |
Polinucleotidos moduladores.
|
|
EP3464565A4
(en)
|
2016-05-25 |
2020-01-01 |
Terumo BCT, Inc. |
CELL EXPANSION
|
|
EP3464331B1
(en)
|
2016-05-30 |
2020-10-28 |
Janssen Vaccines & Prevention B.V. |
Stabilized pre-fusion rsv f proteins
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
JP6683847B2
(ja)
|
2016-06-20 |
2020-04-22 |
ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． |
強力でバランスのとれた双方向性プロモーター
|
|
JP7229151B2
(ja)
|
2016-07-14 |
2023-02-27 |
ヤンセン ファッシンズ アンド プリベンション ベーフェー |
Ｈｐｖワクチン
|
|
JP2019531787A
(ja)
|
2016-08-30 |
2019-11-07 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
生物医学的ターゲティング及びデリバリーの方法並びにそれを実行するための装置及びシステム
|
|
EP3522920A2
(en)
|
2016-10-10 |
2019-08-14 |
Transgene SA |
Immunotherapeutic product and mdsc modulator combination therapy
|
|
US20180119141A1
(en)
|
2016-10-28 |
2018-05-03 |
Massachusetts Institute Of Technology |
Crispr/cas global regulator screening platform
|
|
US10294452B2
(en)
|
2016-11-22 |
2019-05-21 |
Dao-Yao He |
Lysis, extraction and purification of adeno-associated virus and adenovirus from host cells
|
|
CN108085301B
(zh)
*
|
2016-11-22 |
2021-10-26 |
贺道耀 |
从宿主细胞提取和纯化腺相关病毒和腺病毒的方法及其组分和试剂盒
|
|
WO2018106888A1
(en)
*
|
2016-12-08 |
2018-06-14 |
Temple University-Of The Commonwealth System Of Higher Education |
Small animal models for in vivo testing of polyomavirus therapeutics
|
|
WO2018148246A1
(en)
|
2017-02-07 |
2018-08-16 |
Massachusetts Institute Of Technology |
Methods and compositions for rna-guided genetic circuits
|
|
WO2018184028A2
(en)
|
2017-03-31 |
2018-10-04 |
Terumo Bct, Inc. |
Cell expansion
|
|
CN119491003A
(zh)
|
2017-05-05 |
2025-02-21 |
沃雅戈治疗公司 |
治疗亨廷顿病的组合物和方法
|
|
EP3618839A4
(en)
|
2017-05-05 |
2021-06-09 |
Voyager Therapeutics, Inc. |
Compositions and methods of treating amyotrophic lateral sclerosis (als)
|
|
CA3061278A1
(en)
|
2017-05-17 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Methods and compositions for inducing protective immunity against rsv infection
|
|
JOP20190269A1
(ar)
|
2017-06-15 |
2019-11-20 |
Voyager Therapeutics Inc |
بولي نوكليوتيدات aadc لعلاج مرض باركنسون
|
|
CA3070087A1
(en)
|
2017-07-17 |
2019-01-24 |
Voyager Therapeutics, Inc. |
Trajectory array guide system
|
|
EP3662060A2
(en)
|
2017-08-03 |
2020-06-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
CN107384873A
(zh)
*
|
2017-09-05 |
2017-11-24 |
成都汇宇生物技术有限公司 |
重组腺病毒的纯化方法
|
|
CA3073790A1
(en)
|
2017-09-15 |
2019-03-21 |
Janssen Vaccines & Prevention B.V. |
Method for the safe induction of immunity against rsv
|
|
EP3687582A4
(en)
|
2017-09-29 |
2021-07-14 |
Voyager Therapeutics, Inc. |
RESCUE OF CENTRAL AND PERIPHERAL NEUROLOGICAL PHENOTYPE OF FRIEDREICH ATAXIA BY INTRAVENOUS ADMINISTRATION
|
|
CN111479924B
(zh)
|
2017-10-16 |
2024-06-14 |
沃雅戈治疗公司 |
肌萎缩性侧索硬化症(als)的治疗
|
|
EP4454654A3
(en)
|
2017-10-16 |
2025-02-19 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis (als)
|
|
CA3080656A1
(en)
|
2017-10-30 |
2019-05-09 |
Baxalta GmbH |
Environmentally compatible detergents for inactivation of lipid-enveloped viruses
|
|
CN111527202B
(zh)
*
|
2017-11-08 |
2024-03-29 |
蓝天免疫疗法有限责任公司 |
So3色谱在病毒纯化方法中的应用
|
|
WO2019173434A1
(en)
|
2018-03-06 |
2019-09-12 |
Voyager Therapeutics, Inc. |
Insect cell manufactured partial self-complementary aav genomes
|
|
WO2019210137A1
(en)
|
2018-04-27 |
2019-10-31 |
Voyager Therapeutics, Inc. |
Methods for measuring the potency of aadc viral vectors
|
|
JP2021523914A
(ja)
|
2018-05-15 |
2021-09-09 |
ボイジャー セラピューティクス インコーポレイテッドＶｏｙａｇｅｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． |
パーキンソン病を治療するための組成物および方法
|
|
US20210230632A1
(en)
|
2018-05-15 |
2021-07-29 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
US20210207167A1
(en)
|
2018-05-16 |
2021-07-08 |
Voyager Therapeutics, Inc. |
Aav serotypes for brain specific payload delivery
|
|
WO2019222444A2
(en)
|
2018-05-16 |
2019-11-21 |
Voyager Therapeutics, Inc. |
Directed evolution
|
|
WO2020010042A1
(en)
|
2018-07-02 |
2020-01-09 |
Voyager Therapeutics, Inc. |
Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
|
|
EP3817763B1
(en)
|
2018-07-03 |
2025-09-03 |
SOTIO Biotech Inc. |
Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof
|
|
AU2019310459A1
(en)
|
2018-07-24 |
2021-02-18 |
Voyager Therapeutics, Inc. |
Systems and methods for producing gene therapy formulations
|
|
WO2020037066A1
(en)
|
2018-08-14 |
2020-02-20 |
Unum Therapeutics Inc. |
Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating krebs cycle and therapeutic uses thereof
|
|
US12172108B2
(en)
|
2018-08-16 |
2024-12-24 |
Emd Millipore Corporation |
Closed bioprocessing device
|
|
CA3110837A1
(en)
|
2018-08-28 |
2020-03-05 |
Vor Biopharma Inc. |
Genetically engineered hematopoietic stem cells and uses thereof
|
|
MX2021003303A
(es)
|
2018-09-21 |
2021-06-23 |
Univ Connecticut |
Composiciones y metodos para restaurar la expresion del gen ube3a paterno en sindrome de angelman humano.
|
|
JP7528066B2
(ja)
|
2018-09-28 |
2024-08-05 |
ボイジャー セラピューティクス インコーポレイテッド |
操作されたプロモータを有するフラタキシン発現コンストラクトおよびその使用方法
|
|
EP3861010A1
(en)
|
2018-10-02 |
2021-08-11 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
US20210348242A1
(en)
|
2018-10-04 |
2021-11-11 |
Voyager Therapeutics, Inc. |
Methods for measuring the titer and potency of viral vector particles
|
|
US20210371470A1
(en)
|
2018-10-12 |
2021-12-02 |
Voyager Therapeutics, Inc. |
Compositions and methods for delivery of aav
|
|
EP3880243A1
(en)
|
2018-11-13 |
2021-09-22 |
Janssen Vaccines & Prevention B.V. |
Stabilized pre-fusion rsv f proteins
|
|
CA3122085A1
(en)
*
|
2018-12-11 |
2020-06-18 |
Erbi Biosystems, Inc. |
Methods of manufacturing cell based products using small volume perfusion processes
|
|
SG11202107645RA
(en)
|
2019-01-18 |
2021-08-30 |
Voyager Therapeutics Inc |
Methods and systems for producing aav particles
|
|
WO2020172509A1
(en)
|
2019-02-21 |
2020-08-27 |
Unleash Immuno Oncolytics, Inc. |
Oncolytic adenoviral vector and methods of use
|
|
CN110093455B
(zh)
*
|
2019-04-27 |
2020-03-17 |
中国医学科学院病原生物学研究所 |
一种呼吸道病毒的检测方法
|
|
TW202106879A
(zh)
|
2019-04-29 |
2021-02-16 |
美商航海家醫療公司 |
於生物反應器中生產經桿狀病毒感染之昆蟲細胞(biic)之系統及方法
|
|
WO2020227515A1
(en)
|
2019-05-07 |
2020-11-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the vectored augmentation of protein destruction, expression and/or regulation
|
|
CN112175996A
(zh)
*
|
2019-07-05 |
2021-01-05 |
杭州荣泽生物科技有限公司 |
一种基因治疗载体的制备方法和用途
|
|
EP4010465A1
(en)
|
2019-08-09 |
2022-06-15 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
TW202122582A
(zh)
|
2019-08-26 |
2021-06-16 |
美商航海家醫療公司 |
病毒蛋白之控制表現
|
|
WO2021046155A1
(en)
|
2019-09-03 |
2021-03-11 |
Voyager Therapeutics, Inc. |
Vectorized editing of nucleic acids to correct overt mutations
|
|
WO2021097366A1
(en)
*
|
2019-11-15 |
2021-05-20 |
City Of Hope |
System, device and method for production of bioproduct including high density cell respirator for intensified production of adeno-associated viruses
|
|
CN110894494B
(zh)
*
|
2019-11-22 |
2022-09-27 |
广西梧州制药（集团）股份有限公司 |
一种大规模高密度悬浮培养293细胞高产腺病毒的方法
|
|
WO2021202651A1
(en)
|
2020-04-01 |
2021-10-07 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
IL297200A
(en)
|
2020-04-15 |
2022-12-01 |
Voyager Therapeutics Inc |
tau binding compounds
|
|
GB202005732D0
(en)
|
2020-04-20 |
2020-06-03 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
CA3182970A1
(en)
|
2020-05-13 |
2021-11-18 |
Voyager Therapeutics, Inc. |
Redirection of tropism of aav capsids
|
|
WO2022032153A1
(en)
|
2020-08-06 |
2022-02-10 |
Voyager Therapeutics, Inc. |
Cell culture medium for use in producing gene therapy products in bioreactors
|
|
GB202013940D0
(en)
|
2020-09-04 |
2020-10-21 |
Synpromics Ltd |
Regulatory nucleic acid sequences
|
|
CN112226418B
(zh)
*
|
2020-09-25 |
2022-07-08 |
阜外华中心血管病医院 |
重组腺相关病毒纯化方法
|
|
US20230374542A1
(en)
|
2020-10-07 |
2023-11-23 |
Asklepios Biopharmaceutical, Inc. |
Therapeutic adeno-associated virus delivery of fukutin related protein (fkrp) for treating dystroglycanopathy. disorders including limb girdle 21 (lgmd21)
|
|
CN112293394B
(zh)
*
|
2020-10-30 |
2022-11-25 |
海南德安欣有害生物防治科技有限公司 |
一种捕鼠装置及捕鼠方法
|
|
IL302128A
(en)
|
2020-11-02 |
2023-06-01 |
Biomarin Pharm Inc |
A process for the enrichment of adeno-associated virus
|
|
GB202019454D0
(en)
*
|
2020-12-10 |
2021-01-27 |
Chancellor Masters And Scholars Of The Univ Of Oxford |
Method for purifying virus
|
|
US20240141378A1
(en)
|
2021-03-03 |
2024-05-02 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2022187473A2
(en)
|
2021-03-03 |
2022-09-09 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
AU2022256479A1
(en)
|
2021-04-16 |
2023-11-30 |
AskBio Inc. |
Rational polyploid aav virions that cross the blood brain barrier and elicit reduced humoral response
|
|
JP2024533174A
(ja)
|
2021-09-03 |
2024-09-12 |
ビオマリン プハルマセウトイカル インコーポレイテッド |
Ａａｖカプシド組成物及び送達方法
|
|
US20250122530A1
(en)
|
2021-09-03 |
2025-04-17 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
US20240376496A1
(en)
|
2021-09-03 |
2024-11-14 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
WO2023034990A1
(en)
|
2021-09-03 |
2023-03-09 |
Biomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
WO2023034980A1
(en)
|
2021-09-03 |
2023-03-09 |
Bomarin Pharmaceutical Inc. |
Aav capsid compositions and methods for delivery
|
|
JP2024534888A
(ja)
|
2021-09-03 |
2024-09-26 |
ビオマリン プハルマセウトイカル インコーポレイテッド |
Ａａｖカプシド組成物及び送達方法
|
|
US20250223376A1
(en)
|
2021-09-20 |
2025-07-10 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of her2 positive cancer
|
|
IL311712A
(en)
|
2021-09-27 |
2024-05-01 |
Sotio Biotech Inc |
Chimeric receptor polypeptides in combination with trans metabolism molecules that re-direct glucose metabolites out of the glycolysis pathway and therapeutic uses thereof
|
|
MX2024004936A
(es)
|
2021-11-02 |
2024-05-08 |
Voyager Therapeutics Inc |
Variantes de capsides de aav y sus usos.
|
|
CN118488969A
(zh)
|
2021-11-16 |
2024-08-13 |
舒迪安生物技术公司 |
粘液样/圆形细胞脂肪肉瘤患者的治疗
|
|
WO2023091948A1
(en)
|
2021-11-17 |
2023-05-25 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
CA3240342A1
(en)
|
2021-12-16 |
2023-06-22 |
Gopal SAPKOTA |
Targeted degradation of alpha-synuclein
|
|
EP4469585A2
(en)
|
2022-01-25 |
2024-12-04 |
Voyager Therapeutics, Inc. |
Baculovirus expression system
|
|
EP4476241A1
(en)
|
2022-02-08 |
2024-12-18 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
GB202201713D0
(en)
|
2022-02-10 |
2022-03-30 |
Univ Dundee |
An affinity directed phosphatase system for targeted protein dephosphorylation
|
|
CN115354033A
(zh)
*
|
2022-03-25 |
2022-11-18 |
上海碧博生物医药科技有限公司 |
一种细胞裂解液、细胞裂解方法及该方法在收获aav的应用
|
|
EP4532515A1
(en)
|
2022-06-02 |
2025-04-09 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
AR129733A1
(es)
|
2022-06-28 |
2024-09-25 |
Voyager Therapeutics Inc |
Variantes de cápsides de aav y sus usos
|
|
AR129843A1
(es)
|
2022-07-06 |
2024-10-02 |
Voyager Therapeutics Inc |
Variantes de la cápside de aav y usos de estas
|
|
WO2024040207A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered natural killer (nk) cells with chimeric receptor polypeptides in combination with trans metabolism molecules and therapeutic uses thereof
|
|
WO2024040208A1
(en)
|
2022-08-19 |
2024-02-22 |
Sotio Biotech Inc. |
Genetically engineered immune cells with chimeric receptor polypeptides in combination with multiple trans metabolism molecules and therapeutic uses thereof
|
|
WO2024054983A1
(en)
|
2022-09-08 |
2024-03-14 |
Voyager Therapeutics, Inc. |
Controlled expression of viral proteins
|
|
WO2024059739A1
(en)
|
2022-09-15 |
2024-03-21 |
Voyager Therapeutics, Inc. |
Tau binding compounds
|
|
EP4590839A1
(en)
|
2022-09-22 |
2025-07-30 |
Dinaqor AG |
Treatment of cardiomyopathy with aav gene therapy vectors
|
|
WO2024064863A2
(en)
|
2022-09-22 |
2024-03-28 |
Biomarin Pharmaceutical Inc. |
Treatment of arrhythmogenic cardiomyopathy with aav gene therapy vectors
|
|
WO2024215987A1
(en)
|
2023-04-14 |
2024-10-17 |
Sotio Biotech Inc. |
IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-15/IL-15Rα CONJUGATES
|
|
WO2024215989A1
(en)
|
2023-04-14 |
2024-10-17 |
Sotio Biotech Inc. |
ENGINEERED IMMUNE CELLS FOR TREATING CANCER IN COMBINATION WITH IL-2/IL-15 RECEPTOR βγ AGONISTS
|
|
WO2024226790A1
(en)
|
2023-04-26 |
2024-10-31 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2024229173A2
(en)
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
CN121127597A
(zh)
|
2023-05-03 |
2025-12-12 |
沃雅戈治疗公司 |
用于治疗与葡糖苷酰鞘氨醇酶β1缺陷相关的病症的组合物及方法
|
|
CN121079310A
(zh)
|
2023-05-03 |
2025-12-05 |
沃雅戈治疗公司 |
用于治疗与cdkl5缺乏相关的病症的组合物及方法
|
|
WO2024229164A2
(en)
|
2023-05-03 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2024229425A1
(en)
|
2023-05-04 |
2024-11-07 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
WO2025030010A1
(en)
|
2023-08-01 |
2025-02-06 |
Vor Biopharma Inc. |
Compositions comprising genetically engineered hematopoietic stem cells and methods of use thereof
|
|
WO2025038430A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
AR133562A1
(es)
|
2023-08-16 |
2025-10-08 |
Voyager Therapeutics Inc |
Composiciones y métodos para el tratamiento de trastornos relacionados con la deficiencia de frataxina
|
|
WO2025038805A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2025038796A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
WO2025038802A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
WO2025038795A1
(en)
|
2023-08-16 |
2025-02-20 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025122536A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025122532A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to ataxin-2
|
|
TW202540436A
(zh)
|
2023-12-05 |
2025-10-16 |
美商航海家醫療公司 |
用於治療與共濟蛋白(frataxin)缺陷相關之病症之組合物及方法
|
|
WO2025122548A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to cdkl5 deficiency
|
|
WO2025122543A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to syntaxin-binding protein 1 deficiency
|
|
WO2025122530A1
(en)
|
2023-12-05 |
2025-06-12 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to glucosylceramidase beta 1 deficiency
|
|
WO2025137219A1
(en)
|
2023-12-21 |
2025-06-26 |
Voyager Therapeutics, Inc. |
Compositions and methods for the treatment of disorders related to dystrophia myotonica protein kinase
|
|
WO2025147436A1
(en)
|
2024-01-03 |
2025-07-10 |
Voyager Therapeutics, Inc. |
Aav capsid variants and uses thereof
|
|
CN117551624A
(zh)
*
|
2024-01-11 |
2024-02-13 |
深圳源兴基因技术有限公司 |
一种基于无血清悬浮扩增的高效回收腺病毒的方法
|
|
WO2025214477A1
(en)
|
2024-04-12 |
2025-10-16 |
Skyline Therapeutics (Shanghai) Co., Ltd. |
Treatment of genetic cardiomyopathies with aav gene therapy vectors
|